230 related articles for article (PubMed ID: 29528011)
1. FGF23, NGAL, and Endostatin: the Predictors of Allograft Function in Renal Transplant Recipients.
Gürlek Demirci B; Sezer S; Uyanık Yıldırım S; Kaynar Erdoğan M; Tutal E; Özdemir Ö; Orazbayev G; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):136-139. PubMed ID: 29528011
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
[TBL] [Abstract][Full Text] [Related]
3. Urinary neutrophil gelatinase-associated lipocalin and the occurrence of delayed graft function after kidney transplant.
Qurashi S; Ghamdi G; Jaradat M; Tamim H; Aljumah A; Tamimi W; Al Dawood A; Binsalih S; Al Sayyari A
Exp Clin Transplant; 2014 Oct; 12(5):396-400. PubMed ID: 25019387
[TBL] [Abstract][Full Text] [Related]
4. The impact of calcineurin inhibitors on neutrophil gelatinase-associated lipocalin and fibroblast growth factor 23 in long-term kidney transplant patients.
Bleskestad IH; Thorsen IS; Jonsson G; Skadberg Ø; Gøransson LG
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28523792
[TBL] [Abstract][Full Text] [Related]
5. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.
Mitsnefes MM; Kathman TS; Mishra J; Kartal J; Khoury PR; Nickolas TL; Barasch J; Devarajan P
Pediatr Nephrol; 2007 Jan; 22(1):101-8. PubMed ID: 17072653
[TBL] [Abstract][Full Text] [Related]
6. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
[TBL] [Abstract][Full Text] [Related]
7. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Clin Transplant; 2009; 23(5):681-6. PubMed ID: 19708926
[TBL] [Abstract][Full Text] [Related]
8. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
9. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
[TBL] [Abstract][Full Text] [Related]
10. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
[TBL] [Abstract][Full Text] [Related]
12. Urinary Neutrophil Gelatinase-Associated Lipocalin Does Not Distinguish Acute Rejection from Other Causes of Acute Kidney Injury in Pediatric Renal Transplant Recipients.
Seeman T; Vondrak K; Dusek J; Simankova N; Zieg J; Hacek J; Chadimova M; Sopko B; Fortova M
Clin Lab; 2017 Jan; 63(1):111-114. PubMed ID: 28164508
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.
Seifert ME; Ashoor IF; Chiang ML; Chishti AS; Dietzen DJ; Gipson DS; Janjua HS; Selewski DT; Hruska KA
Pediatr Transplant; 2016 May; 20(3):378-87. PubMed ID: 26880121
[TBL] [Abstract][Full Text] [Related]
14. Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?
Buemi A; Musuamba F; Frederic S; Douhet A; De Meyer M; De Pauw L; Darius T; Kanaan N; Wallemacq P; Mourad M
Clin Biochem; 2014 Oct; 47(15):68-72. PubMed ID: 25011070
[TBL] [Abstract][Full Text] [Related]
15. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M
Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
[TBL] [Abstract][Full Text] [Related]
16. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women.
Xu Y; Ma X; Pan X; He X; Xiao Y; Bao Y
Cardiovasc Diabetol; 2018 Nov; 17(1):143. PubMed ID: 30424752
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
[TBL] [Abstract][Full Text] [Related]
18. Endostatin Is an Independent Risk Factor of Graft Loss after Kidney Transplant.
Chu C; Hasan AA; Gaballa MMS; Zeng S; Xiong Y; Elitok S; Krämer BK; Hocher B
Am J Nephrol; 2020; 51(5):373-380. PubMed ID: 32320989
[TBL] [Abstract][Full Text] [Related]
19. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
[TBL] [Abstract][Full Text] [Related]
20. P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation - The CONTEXT study.
Nielsen MB; Krogstrup NV; Nieuwenhuijs-Moeke GJ; Oltean M; Dor FJMF; Jespersen B; Birn H
PLoS One; 2019; 14(2):e0212676. PubMed ID: 30817778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
